Calculated based on number of publications stored in Pure and citations from Scopus
19992023

Research activity per year

Network

P. H. Jones

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Michael J. Soth

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Steven Mischke

  • Early ADME
  • Hoffmann-La Roche Inc.

External person

Virginie Buggia-Prévot

  • The University of Chicago
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

William J. Ray

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Shaoqing Chen

  • Early ADME
  • Hoffmann-La Roche Inc.

External person

Martin Weisel

  • Early ADME

External person

Barry Goggin

  • Hoffmann-La Roche Inc.

External person

Weiling Liang

  • Early ADME

External person

Kyoungja Hong

  • Hoffmann-La Roche Inc.

External person

Adrian J. Fretland

  • Non-clinical Safety
  • Repare Therapeutics
  • National Institutes of Health
  • Drug Metabolism and Pharmacokinetics

External person

Dave S. Solis

  • Early ADME

External person

Shirley Li

  • Early ADME

External person

Xiaochun Han

  • Hoffmann-La Roche Ltd.
  • Early ADME

External person

Gang Liu

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Andrew D. Schutt

  • Hoffmann-La Roche Inc.

External person

Nam T. Le

  • Early ADME
  • Hoffmann-La Roche Inc.

External person

Stacy W. Remiszewski

  • Early ADME
  • Novartis USA

External person

Yan Lou

  • Early ADME

External person

Ann Polonskaia

  • Hoffmann-La Roche Inc.

External person

Lin Gao

  • Early ADME

External person

Ju Anne Yau

  • University of Texas MD Anderson Cancer Center

External person

John Barker

  • Evotec, AG

External person

Tom Nevins

  • Hoffmann-La Roche Inc.

External person

Jennifer Greer

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Lexicon Genetics Incorporated

External person

Morgan L. McReynolds

  • University of Texas MD Anderson Cancer Center

External person

Sha Huang

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Elisa de Stanchina

  • Memorial Sloan-Kettering Cancer Center

External person

Jeffrey J. Kovacs

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Yi Chen

  • Hoffmann-La Roche Inc.

External person

Kyungjin Kim

  • Hoffmann-La Roche Inc.

External person

Wylie S. Palmer

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Sarah Johnson

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Iteeben D. Mahant

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

David Bartkovitz

  • Hoffmann-La Roche Inc.

External person

Maria E. Di Francesco

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Karl B. Frank

  • Non-clinical Safety

External person

John F. Boylan

  • Hoffmann-La Roche Inc.
  • Celgene Corporation

External person

Jay Theroff

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jason B. Cross

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Mary Geck Do

  • University of Texas MD Anderson Cancer Center

External person

Qi Wu

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Angela L. Harris

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Lexicon Genetics Incorporated
  • Department of Metabolism Research

External person

Robert A. Mullinax

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • Lexicon Genetics Incorporated

External person

Hannah E. Shepard

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Ahmed A. Ahmed

  • University of Oxford
  • Oxford University Hospitals NHS Foundation Trust
  • University of Texas MD Anderson Cancer Center
  • University of Cambridge
  • University of Toronto
  • Ovarian Cancer Cell Laboratory
  • Nuffield Department of Obstetrics and Gynaecology
  • Cancer Research Campaign Human Cancer Genetics Group
  • Department of Oncology
  • Department of Experimental Therapeutics
  • Department of Oncology
  • Nuffield Department of Obstetrics and Gynaecology
  • Nuffield Department of Obstetrics and Gynaeoclogy
  • Nuffield Department of Women's and Reproductive Health
  • University of Texas Health Science Center at Houston
  • NIHR Oxford Biomedical Research Centre
  • John Radcliffe Hospital
  • National Institute for Health and Care Research

External person

Maojie Yang

  • Cleveland Clinic Foundation
  • Department of Cancer Biology
  • Houston Methodist
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Mary E. Hamby

  • University of Texas MD Anderson Cancer Center

External person

Nakia D. Spencer

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Jia Ju Bao

  • Box 355
  • Univ. Texas M. D. Andersen Cancer C.
  • University of Texas MD Anderson Cancer Center
  • Department of Molecular Pathology
  • Department of Molecular Pathology
  • University of Texas Health Science Center at Houston

External person

Jennifer Lo

  • Early ADME

External person

Robert A. Goodnow

  • Hoffmann-La Roche Inc.

External person

Goli Naderi-Oboodi

  • Hoffmann-La Roche Inc.

External person

Jason P. Burke

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

C. M. Rudin

  • Johns Hopkins
  • Johns Hopkins University School of Medicine
  • Memorial Sloan-Kettering Cancer Center
  • Johns Hopkins University
  • The University of Chicago
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Department of Oncology
  • Fox Chase Cancer Center
  • Cornell University
  • Thoracic Oncology Service
  • Molecular Chemistry and Pharmacology Program
  • Department of Medical Oncology
  • Department of Oncology
  • Department of Oncology
  • Case Western Reserve University
  • Weill Cornell Medical Center

External person

Robert T. Taylor

  • Non-clinical Safety

External person

Jianping Cai

  • Hoffmann-La Roche Inc.

External person

Shahid Tannu

  • Hoffmann-La Roche Inc.

External person

Donna B. Badgwell

  • University of Texas Health Science Center at Houston
  • Box 355
  • M.D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • Cytokine Research Laboratory
  • Unit 1439

External person

Carlo Toniatti

  • University of Texas MD Anderson Cancer Center
  • IRBM/Merck Research Laboratories
  • Merck
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • ORBIT (Oncology Research for Biologics and Immunotherapy Translation)
  • Department of Oncology
  • Department of Oncology
  • University of Texas Health Science Center at Houston
  • IRBM S.p.A.

External person

Mark Dvorozniak

  • Hoffmann-La Roche Inc.

External person

G. K. Suh

  • Box 355
  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • Departments of Experimentalherapeutics

External person

Zhi Chen

  • Hoffmann-La Roche Inc.

External person

Barbara Czako

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Timothy P. Heffernan

  • University of Texas MD Anderson Cancer Center
  • Harvard University
  • Dana-Farber Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • C4 Therapeutics
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • Belfer Institute for Applied Cancer Science
  • Department of Medical Oncology
  • Belfer Institute for Applied Cancer Science
  • Department of Medical Oncology
  • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
  • Cornell University
  • Department of Medicine
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston
  • C4 Therapeutics, Inc.

External person

Weiguo Qing

  • Hoffmann-La Roche Inc.
  • Hutchison Medi Pharma

External person

Bruce L. Roth

  • University of Texas Health Science Center at Houston

External person

W. S-L Liao

  • Box 355
  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics

External person

Yinhua Yu

  • University of Texas MD Anderson Cancer Center
  • Immunopharmacology and Targeted Therapy Laboratory
  • Depts. Exp. Therapeut. Molec. T.
  • Department of Molecular Oncology
  • Cytokine Research Laboratory
  • Department of Clinical Investigation
  • Department of Experimental Therapeutics
  • Obstetrics and Gynecology Hospital of Fudan University
  • Department of Obstetrics and Gynecology
  • Fudan University
  • Dept. of Experimental Theraupeutics
  • Shanghai Key Laboratory of Female Reproductive Endocrine-Related Disease
  • Department of Gynecology
  • Obstetrics and Gynecology Hospital of Fudan University
  • Department of Clinical Laboratory
  • Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases
  • Department of Obstetrics and Gynecology of Shanghai Medical School
  • Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases
  • Obstetrics and Gynecology Hospital
  • Harvard University
  • Chinese Academy of Medical Sciences
  • Duke University
  • Departments of Medicine
  • BETHLEHEM
  • Obstetrics-Gynecology
  • Department of Obstetrics and Gynecology
  • Microbiology anil Immunology
  • Departments of Medicine
  • Peking Union Medical College
  • Department of Experimental Therapeutics
  • Department of Experimental Medicine
  • Departments of Medicine Duke
  • Department of Medicine
  • Departments of Medicine
  • University of Texas Health Science Center at Houston

External person

Michelle Han

  • University of Texas MD Anderson Cancer Center

External person

Brett Abrahams

  • Magnolia Neurosciences Corporation

External person

Yingsi Chen

  • Hoffmann-La Roche Inc.

External person

Shelli R. Kesler

  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine

External person

Qi Wu

  • University of Texas MD Anderson Cancer Center

External person

Chaitali Chakraborty

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Peter M. Wovkulich

  • Hoffmann-La Roche Inc.
  • Hoffmann-La Roche Ltd.

External person

Jason Gay

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • University of Texas Health Science Center at Houston

External person

Zhijun Kang

  • University of Texas MD Anderson Cancer Center

External person

Kin Chun Luk

  • Hoffmann-La Roche Inc.

External person

Meredith Miller

  • University of Texas MD Anderson Cancer Center

External person

Christine Tardell

  • Hoffmann-La Roche Inc.

External person

Mario Cardozo

  • Nurix, Inc.
  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Imran Jamal

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Fengqin Gao

  • Box 355
  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Texas Health Science Center at Houston

External person

Norma Rogers

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jill Garvey

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Xin Jie Chu

  • Hoffmann-La Roche Inc.

External person

Zachary Herrera

  • University of Texas MD Anderson Cancer Center

External person

Paul McEwan

  • Evotec, AG

External person

Jennifer Warner-Schmidt

  • Magnolia Neurosciences Corporation

External person

Cheng Hui Hu

  • University of Texas MD Anderson Cancer Center

External person

Norman Kong

  • Early ADME

External person

Edmund C. Lee

  • Hoffmann-La Roche Inc.

External person

W. Chen

  • AmeriPath/Quest Diagnostics
  • Box 355
  • University of Texas M.D. Anderson Cancer Center
  • Ameripath/Quest Diagnostics
  • University Texas M. D. Anderson Cancer Center
  • Department of Pathology
  • University of Texas MD Anderson Cancer Center
  • University of Texas Southwestern Medical Center
  • University of Texas at Austin
  • Department of Leukemia
  • Departments of Dermatology and Hematopathology
  • Department of Pathology
  • Department of Experimental Therapeutics
  • Department of Hematopathology
  • Departments of Pathology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology and Laboratory Medicine
  • Quest Diagnostics Incorporated
  • Department of Pathology
  • Departments of Medicine and Pathology
  • University of Texas at Dallas
  • Quest Diagnostics Incorporated
  • Departments of Pathology
  • University of Texas Health Science Center at Houston

External person